Skip to content

CA Final · Financial Reporting · Ind AS 116 Leases

Tejas Pharma Ltd. has a floating-rate lease liability whose payments were linked to an interbank benchmark rate. The benchmark was replaced under interest rate benchmark reform and the contractual cash flows changed as a direct consequence. The CFO asks about the source and effective date of the relief for lessees. Which statement is correct as per Ind AS 116?

The Phase 2 interest rate benchmark reform amendments added paragraphs 104–106 and C20C–C20D to Ind AS 116. They apply to annual reporting periods beginning on or after 1 April 2021, and they were not confined to lessors or to Ind AS 8.

  1. AThe Phase 2 amendments added paragraphs 104–106 and C20C–C20D to Ind AS 116 and apply to annual periods beginning on or after 1 April 2021Correct
  2. BThe Phase 2 amendments added paragraphs 104–106 and C20C–C20D and apply to annual periods beginning on or after 1 April 2023
  3. CThe relief arises from Ind AS 8 only; Ind AS 116 was not amended by Phase 2
  4. DThe Phase 2 amendments apply only to lessors and only to periods beginning on or after 1 April 2021

Explanation

Interest Rate Benchmark Reform Phase 2 amended Ind AS 109, Ind AS 107, Ind AS 104 and Ind AS 116, adding paragraphs 104–106 and C20C–C20D, applicable for annual reporting periods beginning on or after 1 April 2021. The 2023 date and the claim that Ind AS 116 was not amended are therefore wrong. Nothing limits the amendments to lessors.

Did you get it right without looking?

One question tells you little. A timed set on Ind AS 116 Leases shows your real accuracy, how long you take and where you lose marks.

More Ind AS 116 Leases questions